Beta-O2 Technologies Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Employees
-
15
- Latest Deal Type
-
Out of Business
Beta-O2 Technologies General Information
Description
Developer of a bio-artificial pancreas designed to help cure diabetes. The company's device is implantable and provides a viable and safe environment for pancreatic IOL inside a subcutaneously implanted bioreactor which helps the cells to thrive, functioning natively and provides the body with the essential hormones in the correct ratio, and solving the challenges of islet transplantation like adequate oxygen supply by supplying oxygen to contained cells and full immune-protection, enabling patients to be freed from risky and morbidity-inducing immune-suppressive drugs therapy.
Contact Information
Website
www.beta-o2.comCorporate Office
- 11 Amal Street
- Post office Box 11793
- Rosh Haayin 4809900
- Israel
Corporate Office
- 11 Amal Street
- Post office Box 11793
- Rosh Haayin 4809900
- Israel
Beta-O2 Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 15-Aug-2025 | Completed | Out of Business | |||
| 5. Later Stage VC (Series B) | 03-Sep-2018 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 30-Mar-2015 | Completed | Clinical Trials - Phase 1 | |||
| 3. Grant | 10-Sep-2014 | Completed | Startup | |||
| 2. Early Stage VC | 06-Feb-2007 | $5M | $7M | Completed | Startup | |
| 1. Seed Round | 08-Mar-2004 | $2M | $2M | Completed | Startup |
Beta-O2 Technologies Patents
Beta-O2 Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190125937-A1 | Implantable device for implantation of cells having anti-inflammatory and vascularization capabilities and methods of making thereof | Inactive | 04-Apr-2016 | ||
| WO-2017175065-A2 | Implantable device for implantation of cells having anti-inflammatory and vascularization capabilities and methods of making thereof | Inactive | 04-Apr-2016 | ||
| WO-2017175065-A3 | Implantable device for implantation of cells having anti-inflammatory and vascularization capabilities and methods of making thereof | Inactive | 04-Apr-2016 | ||
| JP-2019501808-A | Implantable device for transplantation of cells with anti-inflammatory and angiogenic potential and method for producing the same | Pending | 04-Apr-2016 | ||
| JP-2019503828-A | System and method for providing oxygen to transplanted cells | Pending | 08-Feb-2016 | A61L27/3804 |
Beta-O2 Technologies Signals
Beta-O2 Technologies FAQs
-
When was Beta-O2 Technologies founded?
Beta-O2 Technologies was founded in 2004.
-
Where is Beta-O2 Technologies headquartered?
Beta-O2 Technologies is headquartered in Rosh Haayin, Israel.
-
What is the size of Beta-O2 Technologies?
Beta-O2 Technologies has 15 total employees.
-
What industry is Beta-O2 Technologies in?
Beta-O2 Technologies’s primary industry is Therapeutic Devices.
-
Is Beta-O2 Technologies a private or public company?
Beta-O2 Technologies is a Private company.
-
What is Beta-O2 Technologies’s current revenue?
The current revenue for Beta-O2 Technologies is .
-
How much funding has Beta-O2 Technologies raised over time?
Beta-O2 Technologies has raised $39.5M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process